Cancer Control and Prevention Protocols, Treatment Protocols
Adjuvant Breast, Breast
A Randomized Phase III Double-Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Patients previously enrolled in A011502 patients are eligible for enrollment in companion study A211601 and may be consented with A211601 Retrospective Consent.
Patients enrolling in A011502 patients must be enrolled in companion study A211601 and may be consented with A211601 Consent.
Eligible for screening study DCP 001